CLINICAL STAGE III CUTANEOUS MERKEL CELL CARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE III CUTANEOUS MERKEL CELL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE III CUTANEOUS MERKEL CELL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE III CUTANEOUS MERKEL CELL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kidney transplant patients with advanced skin cancer: immune-boosting combo tested
Disease control Recruiting nowThis study tests whether combining two immunotherapy drugs (nivolumab and ipilimumab) with two anti-rejection medications (sirolimus and prednisone) can control advanced skin cancer in kidney transplant recipients without losing the transplanted kidney. About 16 adults with skin …
Matched conditions: CLINICAL STAGE III CUTANEOUS MERKEL CELL CARCINOMA AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
Insurance delays may hurt skin cancer outcomes, new study investigates
Knowledge-focused Recruiting nowThis study tracks 70 skin cancer patients to see how long it takes to get insurance approval for 'off-label' drugs given before surgery. Researchers will measure costs, approval times, and whether delays lead to worse surgical outcomes. The goal is to understand barriers to timel…
Matched conditions: CLINICAL STAGE III CUTANEOUS MERKEL CELL CARCINOMA AJCC V8
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 11:33 UTC